Health

Results: 421-432 of 6717

PR Newswire associated0

LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company

Government to combat flu outbreaks by removing red tape

Oslo University Hospital to conduct randomized phase 2 trial of ILB® in ALS; Tikomed to supply ILB for both study phases

PR Newswire associated0

AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction

Jenscare Announces 2025H1 Interim Results

Business Wire logo

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Business Wire logo

Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C

Business Wire logo

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

US FDA approves Leqembi® IQKLIK™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease

PR Newswire associated0

Smile Hair Clinic Becomes the First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS

Embla Medical hf: Embla Medical closes the majority share investment in Streifeneder ortho.production GmbH

Seminar: IP That Matters - Behind Orexo's Milestone Patent Win at the US Court